Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Acupuncture may help people suffering from chronic tension-type headaches

Acupuncture may reduce headaches for people who have chronic tension-type headaches, according to a study published in the June 22, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

22 Jun 2022

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

Previous studies have looked for links between glaucoma - a neurodegenerative disorder that's the leading cause of irreversible blindness - and cognitive function, but they've generated mixed results.

22 Jun 2022

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

In a recent review published in Immunity, researchers explored potential mechanisms of neuro-immune pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Jun 2022

Study highlights low use of mental health services in Australian residential aged care facilities

Less than 3% of people with mental health conditions living in Australian residential aged care facilities accessed government-subsidised mental health services, a new analysis from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI) has found, with calls for organisational and policy changes to improve access.

22 Jun 2022

Moderna to build large-scale mRNA manufacturing center in the UK

NHS patients will have access to the next generation of vaccines and treatments following an agreement between the government and Moderna to build a state-of-the-art manufacturing and research and development centre in the UK.

21 Jun 2022

A class of protein-cleaving enzymes suspected to play a role in hereditary brain disease

Similar to Alzheimer's disease, the hereditary disease spinocerebellar ataxia type 17 (SCA17) leads to the destruction of brain nerve cells and the premature death of patients.

21 Jun 2022

Increased docosahexaenoic acid intake may lower risk for Alzheimer’s and dementia

An increase in the concentration of DHA in RBCs is associated with a reduced risk of Alzheimer's disease and all-cause dementia

21 Jun 2022

Proteins in liquor could provide information about inflammatory processes in the brain

Alzheimer's, Parkinson's and other neurodegenerative diseases are associated with inflammatory processes in the brain.

20 Jun 2022

MRI-based machine learning approach can accurately predict Alzheimer’s disease

The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer's.

20 Jun 2022

Fragmented sleep, wakefulness after bedtime linked with lower cognitive function among African Americans

More fragmented sleep and longer periods of wakefulness after bedtime among a group of low-income African American adults were associated with lower cognitive function such as poor attention, according to a new study.

16 Jun 2022

Cardiometabolic multimorbidity increases the risk of developing dementia

People with at least two of the diseases type 2 diabetes, heart disease or stroke have double the risk of developing dementia.

16 Jun 2022

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

The cost of brand-name drugs for epilepsy increased by 277% from 2010 to 2018, according to a study published in the June 15, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jun 2022

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with.

15 Jun 2022

Study reveals the dynamics of disease recovery after severe COVID-19

Recovery from severe COVID-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system.

15 Jun 2022

Lifestyle factors play a beneficial role in the prevention of Alzheimer's and related dementias

As rates of Alzheimer's disease and other forms of dementia continue to rise in the U.S., new evidence suggests that lifestyle factors such as diet, exercise and sleep play an important role in reducing the risk of developing dementia.

14 Jun 2022

New near-infrared probe may aid in early diagnosis of Alzheimer's disease

Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer's disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become tainted and destroy cells, which leads to forgetfulness and memory loss.

14 Jun 2022

Scientific statement highlights the need for more data on sex differences in stroke treatment

A new American Heart Association scientific statement highlights the need for more data and research about sex differences in the use and response to mechanical clot removal for acute ischemic stroke and suggests a clear differentiation between sex and gender in future research.

14 Jun 2022

Current evidence on cannabis use in palliative care

Scientists from Wellington, New Zealand, have conducted a systematic review to understand the effectiveness of medicinal cannabis in palliative care settings.

13 Jun 2022

New research provides credible estimates for prevalence of Alzheimer’s-like brain disorder

New National Institutes of Health-funded research shows that the prevalence of brain changes from Limbic-predominant Age-related TDP-43 Encephalopathy (LATE) may be roughly 40% in older adults and as high as 50% in people with Alzheimer's disease.

13 Jun 2022

Study provides the most definitive assessment of new non-Alzheimer’s dementia

Researchers from the University of Kentucky's Sanders-Brown Center on Aging say a paper recently published in Acta Neuropathologica is the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.

13 Jun 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Acupuncture may help people suffering from chronic tension-type headaches

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

Study highlights low use of mental health services in Australian residential aged care facilities

Moderna to build large-scale mRNA manufacturing center in the UK

A class of protein-cleaving enzymes suspected to play a role in hereditary brain disease

Increased docosahexaenoic acid intake may lower risk for Alzheimer’s and dementia

Proteins in liquor could provide information about inflammatory processes in the brain

MRI-based machine learning approach can accurately predict Alzheimer’s disease

Fragmented sleep, wakefulness after bedtime linked with lower cognitive function among African Americans

Cardiometabolic multimorbidity increases the risk of developing dementia

Cost of brand-name antiseizure medications increased by 277% from 2010 to 2018, study finds

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

Study reveals the dynamics of disease recovery after severe COVID-19

Lifestyle factors play a beneficial role in the prevention of Alzheimer's and related dementias

New near-infrared probe may aid in early diagnosis of Alzheimer's disease

Scientific statement highlights the need for more data on sex differences in stroke treatment

Current evidence on cannabis use in palliative care

New research provides credible estimates for prevalence of Alzheimer’s-like brain disorder

Study provides the most definitive assessment of new non-Alzheimer’s dementia

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in